多西紫杉醇联合奥沙利铂和5-氟尿嘧啶治疗晚期胃癌40例临床观察
出处
《齐鲁护理杂志》
2008年第10期120-121,共2页
Journal of Qilu Nursing
参考文献6
-
1Giuliani F, Gebbia V, De Vita F, et al. Docetaxel assalvage therapy in advanced gastric cancer.a phase Ⅱ study of the Gruppo oncologico Italia Meridionale [ J ]. Anticancer Research, 2003,23 ( 5 ) :4219 - 4222.
-
2Bang YJ, Kang WK, Kang YK, et al. Docetaxel 75 mg/m^2 is active and well tolerated in patients with metastatic or recurrent gastric cancer:a phase Ⅱ trial[ J]. Jpn J Clin Oncol,2002,32(7):248.
-
3Furue H, Taguchi T. A late phase Ⅱ clinical study of RP - 56976 (docetaxel) in patients with advanced or recurrent gastric cancer [ J ]. Chemother, 1999,26 (4) :487.
-
4Ridwelski K, Gebauer T, Fahlke J, et al. Combination chemotherapy with docetaxel and cisplatin for locally advanced and metastatic gastric cancer[ J]. Ann Oncol,2001, 12(4) :47.
-
5Constenla M, Carci A, Arroyo R, et al. Docetaxel,5 - Fu and CF as treatment for advanced gastric cancer results of aphase study [ J]. Gastric Cancer, 2002,5 ( 6 ) : 142.
-
6Tahara M. Ohstu A. Latest progress, on chemotherapy for advanced gastric cancer[J]. Tpn J Gan To Kagaku Ryoho, 2000,27 ( 13 ) :2048 - 2058.
-
1谢祠红.多西紫杉醇联合顺铂及5-氟脲嘧啶治疗晚期胃癌近期疗效观察[J].中国医药科学,2013,3(5):86-87. 被引量：4
-
2刘基巍,周涛,张洁,陈亚敏,孙亮新,殷柳,班丽英.多西紫杉醇联合顺铂治疗NSCLC的近期疗效观察[J].中国肺癌杂志,2000,3(5):378-379. 被引量：5
-
3陈强.胃癌化疗的近展[J].胃肠病学,2002,7(3):177-178. 被引量：22
-
4马自勤,靳木兰.5—氟尿嘧啶预防翼状胬肉术后复发观察[J].实用医技杂志,1998,5(6):418-419. 被引量：1
-
5周亮.青光眼小梁切除术后5—氟尿嘧啶的应用[J].实用医学杂志,1996,12(10):689-690.
-
6骆玉霜.多西紫杉醇联合顺铂治疗晚期乳腺癌41例疗效观察[J].山东医药,2008,48(25):4-4. 被引量：1
-
7李争光,吴骏,张红宇.多西紫杉醇联合替吉奥治疗晚期胃癌的近期疗效[J].肿瘤基础与临床,2014,27(4):291-292.
-
8史国兵,马燕,韦平,陈立江.高效液相色谱法测定5-氟尿嘧啶注射液的含量[J].辽宁药物与临床,2003,6(2):69-70. 被引量：5
-
9黄灿,许杜娟,夏泉,苏涌.HPLC法测定肿瘤细胞中5-氟尿嘧啶的浓度[J].安徽医药,2012,16(2):173-174. 被引量：4
-
10郑亮,杨昆.多西紫杉醇联合顺铂治疗晚期非小细胞肺癌的临床观察[J].工企医刊,2006,19(6):57-58.
